Xenetic Biosciences, Inc.
(NASDAQ : XBIO)

( )
XBIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.74%178.160.7%$1431.81m
PFEPfizer Inc. 1.14%50.490.9%$1327.24m
ABBVAbbVie, Inc. 1.44%155.711.9%$1240.79m
BMYBristol-Myers Squibb Co. 1.49%76.931.0%$1167.46m
MRKMerck & Co., Inc. 2.14%92.340.7%$1088.82m
LLYEli Lilly & Co. 2.78%299.731.1%$823.15m
AZNAstraZeneca Plc 2.14%64.491.0%$478.91m
VERUVeru, Inc. 3.85%13.500.0%$403.25m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.38%140.460.0%$394.02m
GSKGlaxoSmithKline Plc 2.42%44.370.2%$223.17m
NVSNovartis AG 2.33%87.820.2%$219.85m
HZNPHorizon Therapeutics Plc 0.43%90.825.4%$198.56m
NVONovo Nordisk A/S -2.65%103.230.1%$166.43m
SGENSeagen Inc. 5.10%142.545.7%$163.52m
CTLTCatalent, Inc. -0.56%97.632.0%$158.65m

Company Profile

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.